Jun 7, 2023Press Releases$325K NIH Phase I Grant: Advancing Urinary Catheter Technology with AvantGuardAvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary...
May 11, 2023Press ReleasesAvantGuard Secures $2.85 Million in Oversubscribed Seed Round Funding to Accelerate Research and DevNEW YORK, May 11, 2023 /PRNewswire/ -- AvantGuard, a fast-growing company in the antimicrobial industry, announced today the successful...
Apr 19, 2023Press ReleasesAvantGuard Receives $1.7M NIH Grant for AvantGuard247™AvantGuard, Inc. is pleased to announce a $1.7 million Phase II SBIR award from the National Institutes of Health (NIH) to continue...
Mar 27, 2023Press ReleasesAvantGuard Unveils New Brand Identity Focusing On Innovative Technologies For a Safer WorldITHACA, N.Y., March 23, 2023 /PRNewswire/ -- AvantGuard, announced today the unveiling of its new brand identity as a transformative...